Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of CIITA (rs8048002) and CLEC2D (rs2114870) gene variants and type 1 diabetes mellitus. | J Diabetes Metab Disord | 2024 | 38932894 | PubTator, text mining | PubMed |
| Effects of early pregnancy on NOD-like receptor expression in the ovine endometrium. | Front Vet Sci | 2024 | 38903689 | PubTator, text mining | PubMed |
| CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice. | Front Genome Ed | 2024 | 38863835 | PubTator, text mining | PubMed |
| Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction. | Clin Mol Hepatol | 2024 | 38741238 | PubTator, text mining | PubMed |
| HLA-DR Expression in Natural Killer Cells Marks Distinct Functional States, Depending on Cell Differentiation Stage. | Int J Mol Sci | 2024 | 38731828 | PubTator, text mining | PubMed |
| Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease. | J Parkinsons Dis | 2024 | 38728204 | PubTator, text mining | PubMed |
| Replication competent HIV-guided CRISPR screen identifies antiviral factors including targets of the accessory protein Nef. | Nat Commun | 2024 | 38714682 | PubTator, text mining | PubMed |
| SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2. | J Cell Sci | 2024 | 38682259 | PubTator, text mining | PubMed |
| PM2.5 Extracts Induce INFγ-Independent Activation of CIITA, MHCII, and Increases Inflammation in Human Bronchial Epithelium. | Toxics | 2024 | 38668515 | PubTator, text mining | PubMed |
| Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | 38619967 | PubTator, text mining | PubMed |
| Harnessing innate immune pathways for therapeutic advancement in cancer. | Signal Transduct Target Ther | 2024 | 38523155 | PubTator, text mining | PubMed |
| Tumor-infiltrating immune cells and survival in head and neck squamous cell carcinoma: a retrospective computational study. | Sci Rep | 2024 | 38493212 | PubTator, text mining | PubMed |
| Compact zinc finger architecture utilizing toxin-derived cytidine deaminases for highly efficient base editing in human cells. | Nat Commun | 2024 | 38360922 | PubTator, text mining | PubMed |
| Rheostats, toggles, and neutrals, Oh my! A new framework for understanding how amino acid changes modulate protein function. | J Biol Chem | 2024 | 38336297 | PubTator, text mining | PubMed |
| Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate. | Cell Stem Cell | 2024 | 38335966 | PubTator, text mining | PubMed |
| Host transcriptomics and machine learning for secondary bacterial infections in patients with COVID-19: a prospective, observational cohort study. | Lancet Microbe | 2024 | 38310908 | PubTator, text mining | PubMed |
| Deciphering Immune-related Gene Signatures in Diabetic Retinopathy: Insights from In silico Analysis and In vitro Experiment. | Curr Pharm Biotechnol | 2024 | 38310446 | PubTator, text mining | PubMed |
| Identification of a novel macrophage-related prognostic signature in colorectal cancer. | Sci Rep | 2024 | 38307957 | PubTator, text mining | PubMed |
| Role of the osteocyte in bone metastasis - The importance of networking. | J Bone Oncol | 2024 | 38304485 | PubTator, text mining | PubMed |
| VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. | Nat Commun | 2024 | 38291039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=9